Deutsch English Français

Contact

EP1945669

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1945669

EP1945669 - CHIMERIC ANTIBODIES WITH NEW WORLD PRIMATE REGIONS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 02.08.2013 Database last updated on 05.10.2024
Most recent event Tooltip	02.08.2013	Application deemed to be withdrawn	published on 04.09.2013 [2013/36]
Applicant(s)	For all designated states Cephalon Australia Pty Ltd Level 2 37 Epping Road Macquarie Park, NSW 2113 / AU
	[N/P]
Former [2010/38]	For all designated states Cephalon Australia Pty Ltd Level 2, 37 Epping Road Macquarie Park NSW 2113 / AU
Former [2008/30]	For all designated states ARANA THERAPEUTICS LIMITED Level 2, 37 Epping Road Macquarie Park New South Wales 2113 / AU
Inventor(s)	01 / JENNINGS, Philip, Anthony 5 Oswald Close Warrawee, New South Wales 2074 / AU
	02 / DOYLE, Anthony, Gerard 6B Plunkett Street Drummoyne, New South Wales 2047 / AU
	03 / CLARKE, Adam, William 7/96-98 Hampden Road Russell Lea, New South Wales 2046 / AU
	[2008/30]
Representative(s)	Care, Alison, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB
	[N/P]
Former [2008/30]	Care, Alison, et al Kilburn & Strode 20 Red Lion Street London WC1R 4PJ / GB
Application number, filing date	06774813.7	15.08.2006
	[2008/30]
	WO2006AU01166
Priority number, date	AU20050904406	15.08.2005 Original published format: AU 2005904406
	[2008/30]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2007019621
	Date:	22.02.2007
	Language:	EN
	[2007/08]
	Type:	A1 Application with search report
	No.:	EP1945669
	Date:	23.07.2008
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 22.02.2007 takes the place of the publication of the European patent application.
	[2008/30]
Search report(s)	International search report - published on:	AU	22.02.2007
	(Supplementary) European search report - dispatched on:	EP	18.06.2009
Classification	IPC:	C07K16/18, A61K39/395, C07K16/46	[2009/27]
	CPC:	C07K16/18 (EP,KR); A61K39/395 (KR); C07K2317/24 (EP); C07K2317/565 (EP)
	Former IPC [2008/30]	C07K16/18, A61K39/395
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/30]
Extension states	AL	17.03.2008
	BA	17.03.2008
	HR	17.03.2008
	MK	17.03.2008
	RS	17.03.2008
Title	German:	CHIMÄRE ANTIKÖRPER MIT NEUWELTPRIMATENREGIONEN	[2008/30]
	English:	CHIMERIC ANTIBODIES WITH NEW WORLD PRIMATE REGIONS	[2008/30]
	French:	ANTICORPS CHIMÉRIQUES AVEC RÉGIONS DE PRIMATES DU NOUVEAU MONDE	[2008/30]
Entry into regional phase	17.03.2008	National basic fee paid
	17.03.2008	Search fee paid
	17.03.2008	Designation fee(s) paid
	17.03.2008	Examination fee paid
Examination procedure	17.03.2008	Examination requested [2008/30]
	26.06.2008	Amendment by applicant (claims and/or description)
	06.10.2009	Despatch of a communication from the examining division (Time limit: M06)
	16.04.2010	Reply to a communication from the examining division
	04.11.2010	Despatch of a communication from the examining division (Time limit: M06)
	25.08.2011	Reply to a communication from the examining division
	01.03.2013	Application deemed to be withdrawn, date of legal effect [2013/36]
	09.04.2013	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2013/36]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 06.10.2009
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the examination report
	25.08.2011	Request for further processing filed
	25.08.2011	Full payment received (date of receipt of payment) Request granted
	07.09.2011	Decision despatched
Fees paid	Renewal fee
	25.03.2008	Renewal fee patent year 03
	12.08.2009	Renewal fee patent year 04
	17.08.2010	Renewal fee patent year 05
	25.08.2011	Renewal fee patent year 06
	Penalty fee
	Additional fee for renewal fee
	31.08.2012	07 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[DY]WO9302108 (IDEC PHARMA CORP [US]) [DY] 1-15 * page 2 - page 12 *;
		[Y]US2003143682 (NICOLAIDES NICHOLAS C [US], et al) [Y] 6,7,13 * page 3, paragraph 27 - page 15, paragraph 53; example 6 *;
		[DY] - VON BUDINGEN HANS-CHRISTIAN ET AL, "Characterization of the expressed immunoglobulin IGHV repertoire in the New World marmoset Callithrix jacchus", IMMUNOGENETICS, (200109), vol. 53, no. 7, ISSN 0093-7711, pages 557 - 563, XP002527012 [DY] 1-15 * the whole document * DOI: http://dx.doi.org/10.1007/s002510100362
		[Y] - SPEIDEL M T ET AL, "Detection of human and marmoset immunoglobulin heavy chain by a polyclonal antiserum to a marmoset immunoglobulin-related T cell product", EXPERIMENTAL AND CLINICAL IMMUNOGENETICS, S.KARGER, BASEL, CH, (19890101), vol. 6, no. 4, ISSN 0254-9670, pages 245 - 250, XP009116561 [Y] 1-15 * the whole document *
		[Y] - REITER Y ET AL, "An antibody single-domain phage display library of a native heavy chain variable region: isolation of functional single-domain VH molecules with a unique interface", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, (19990101), vol. 290, no. 3, ISSN 0022-2836, pages 685 - 698, XP004461990 [Y] 8 * the whole document * DOI: http://dx.doi.org/10.1006/jmbi.1999.2923
		[Y] - HOLT L J ET AL, "Domain antibodies: proteins for therapy", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, (20031101), vol. 21, no. 11, ISSN 0167-7799, pages 484 - 490, XP004467495 [Y] 8 * the whole document * DOI: http://dx.doi.org/10.1016/j.tibtech.2003.08.007
		[Y] - FOOTE J ET AL, "Antibody framework residues affecting the conformation of the hypervariable loops", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 224, no. 2, ISSN 0022-2836, (19920320), pages 487 - 499, (19920320), XP024011188 [Y] 6,7,13 * the whole document * DOI: http://dx.doi.org/10.1016/0022-2836(92)91010-M
	International search	[A] - LANGERMANS J. ET AL., "Reactivity of human T-lymphocyte-specific antibodies with peripheral blood mononuclear cells and spleen of Aotus azarae ssp. boliviensis (owl monkey)", J. MED. PRIMATOL., (2000), vol. 29, pages 397 - 401, XP008077203 DOI: http://dx.doi.org/10.1111/j.1600-0684.2000.290603.x
	Examination	WO0233042
		WO2004003019

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p